Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages.

[1]  J. Hanley,et al.  Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .

[2]  J A Hanley,et al.  Screening for prostate cancer: estimating the magnitude of overdetection. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  H A Guess,et al.  Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. , 2000, JAMA.

[4]  Peter H Gann,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.

[5]  Juni Palmgren,et al.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.

[6]  Lisa M. Schwartz,et al.  Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? , 2003, JAMA.

[7]  M. Cooperberg,et al.  National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.

[8]  T. Stukel,et al.  Prostate-specific antigen screening in elderly men. , 2003, Journal of the National Cancer Institute.

[9]  G. Naglie,et al.  Continued undertreatment of older men with localized prostate cancer. , 2003, Urology.

[10]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[11]  Floyd J Fowler,et al.  Enthusiasm for cancer screening in the United States. , 2004, JAMA.

[12]  J. Hugosson,et al.  Lead time associated with screening for prostate cancer , 2004, International journal of cancer.

[13]  T. Wilt,et al.  Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.